Noelia V. Weisstaub, Ph.D.
Affiliations: | 2007 | Columbia University, New York, NY |
Area:
SerotoninGoogle:
"Noelia Weisstaub"Mean distance: 14.51 (cluster 36) | S | N | B | C | P |
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jaggar M, Banerjee T, Weisstaub N, et al. (2019) 5-HT receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression. Neuronal Signaling. 3: NS20180205 |
| Jaggar M, Weisstaub N, Gingrich JA, et al. (2017) 5-HT2A receptor deficiency alters the metabolic and transcriptional, but not the behavioral, consequences of chronic unpredictable stress. Neurobiology of Stress. 7: 89-102 |
| Goitia B, Rivero-Echeto MC, Weisstaub NV, et al. (2015) Modulation of gaba release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors. Journal of Neurochemistry |
| Lu R, Alioua A, Kumar Y, et al. (2008) c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta. The Journal of Physiology. 586: 3855-69 |
| González-Maeso J, Weisstaub NV, Zhou M, et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 53: 439-52 |
| Weisstaub NV, Zhou M, Lira A, et al. (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (New York, N.Y.). 313: 536-40 |
| González-Maeso J, Yuen T, Ebersole BJ, et al. (2003) Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8836-43 |
| Gingrich JA, Ansorge MS, Merker R, et al. (2003) New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. Cns Spectrums. 8: 572-7 |
| Santarelli L, Saxe M, Gross C, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, N.Y.). 301: 805-9 |
| González-Maeso J, Yuen T, Ebersole BJ, et al. (2003) Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex The Journal of Neuroscience. 23: 8836-8843 |